Pantoprazole Sodium 40mg Delayed-Release Tablets from China
These are oral delayed-release tablets containing 40mg of pantoprazole sodium, a proton pump inhibitor used to treat gastroesophageal reflux disease (GERD) and erosive esophagitis. They fall under HTS 3004.90.92.55 as unmixed medicaments put up in measured doses for retail sale, primarily affecting the digestive system via pantoprazole or its salts.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Verify pantoprazole content via certificate of analysis to confirm classification under 3004.90.92.55; mislabeling risks reclassification
• Ensure FDA registration and NDC labeling for retail packs; provide stability data for delayed-release formulations
• Avoid bulk shipments without measured doses, as they may shift to unmixed chemical headings like 2933